Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age

The incidence of neuroendocrine neoplasia (NEN) is higher in individuals ≥70 years of age (elderly) who are underrepresented in clinical trials because of comorbidities and low performance status. We retrospectively analyzed the outcome of elderly patients with metastatic NEN (mNEN). Comorbidities w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongiovanni, Alberto, Recine, Federica, Foca, Flavia, Fausti, Valentina, Riva, Nada, Fabbri, Greta, Severi, Stefano, Liverani, Chiara, De Vita, Alessandro, Spadazzi, Chiara, Miserocchi, Giacomo, Mercatali, Laura, Amadori, Dino, Ibrahim, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311458/
https://www.ncbi.nlm.nih.gov/pubmed/30530877
http://dx.doi.org/10.1530/EC-18-0478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311458/
https://www.ncbi.nlm.nih.gov/pubmed/30530877
http://dx.doi.org/10.1530/EC-18-0478

Ejemplares similares